Travere Therapeutics, Inc. 4 Filing
Ticker: TVTX · Form: 4 · Filed: May 7, 2026 · CIK: 0001438533
| Field | Detail |
|---|---|
| Company | Travere Therapeutics, Inc. (TVTX) |
| Form Type | 4 |
| Filed Date | May 7, 2026 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 4 filing submitted by Travere Therapeutics, Inc. (ticker: TVTX) to the SEC on May 7, 2026.
Where can I view the full 4 filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on May 7, 2026 regarding Travere Therapeutics, Inc. (TVTX). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.